APRISO is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Mesalamine.
Product ID | 43353-884_08025228-3c71-400b-95ff-80d6aea38f33 |
NDC | 43353-884 |
Product Type | Human Prescription Drug |
Proprietary Name | APRISO |
Generic Name | Mesalamine |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2008-10-31 |
Marketing Category | NDA / NDA |
Application Number | NDA022301 |
Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
Substance Name | MESALAMINE |
Active Ingredient Strength | 375 mg/1 |
Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2014-02-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022301 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-02-17 |
Ingredient | Strength |
---|---|
MESALAMINE | 375 mg/1 |
SPL SET ID: | faaaa4b7-087e-4c50-820d-561f8f39adc8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
43353-884 | APRISO | APRISO |
65649-103 | APRISO | APRISO |
0023-5901 | Asacol HD | mesalamine |
0430-0783 | ASACOL HD | mesalamine |
0023-5853 | Delzicol | mesalamine |
0179-0142 | Lialda | mesalamine |
0093-5907 | Mesalamine | Mesalamine |
0093-9224 | mesalamine | mesalamine |
0378-1375 | Mesalamine | mesalamine |
0378-9230 | Mesalamine | mesalamine |
0472-1915 | Mesalamine | Mesalamine |
0037-0066 | Rowasa | mesalamine |
0037-0022 | sfRowasa | mesalamine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
APRISO 77520068 3743051 Live/Registered |
Salix Pharmaceuticals, Ltd. 2008-07-11 |
APRISO 76333591 2682873 Live/Registered |
APRISO CORP. 2001-11-02 |